To the articles

USP Reference Standards – Standards of the United States Pharmacopeia
USP reference standards are the global quality benchmark for the analytical validation of pharmaceuticals, biologics, and excipients. Manufacturers of APIs, generics, complex biologics, or pharmaceutical raw materials require comparator substances that regulatory authorities and international pharmacopoeias fully trust.
As an authorized USP specialist retailer, we exclusively deliver standards – with the highest product safety, reliable supply chains and valid results for maximum patient safety.
The range of USP reference standards
Our portfolio includes thousands of USP standards , including:
✔ Drug active ingredient standards (APIs)
✔ Excipient standards
✔ Impurities & Degradation Products
✔ Nitrosamine standards
✔ Pharmaceutical Analytical Impurities (PAI)
✔ Analytical Reference Materials (ARM)
✔ Biologics Standards
✔ Compendial reagents
✔ Dissolution Performance Verification Standards (DPVS)
USP Pharmaceutical Analytical Impurities
READ MOREUSP Biologics
READ MOREUSP Analytical Reference Materials
READ MORE| Order no. | Article name | Batch number | CAS Number | Unit Price € | Quantity |
|---|---|---|---|---|---|
|
USP-1708015
Sale price1.058,61 €
|
D-Valganciclovir (10 mg) (2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-methoxy]-3-hydroxypropyl D-valine ester monohydrochloride) |
F0H021 | 1393911-57-3 | 1.058,61 € | |
|
USP-1708650
Sale price951,11 €
|
Valproic Acid Related Compound K (25 mg) (2-Ethyl-2-methylpentanoic acid) |
R188V0 | 5343-52-2 | 951,11 € | |
|
USP-1708718
Sale price1.139,23 €
|
Valproic Acid Related Compound B (50 mg) ((2RS)-2-(1-methylethyl)pentanoic acid) |
R12370 | 62391-99-5 | 1.139,23 € | |
|
USP-1708729
Sale price1.110,02 €
|
Valproic Acid Related Compound A (0.25 mL) (2-allylpent-4-enoic acid) |
R089K0 | 99-67-2 | 1.110,02 € | |
|
USP-1708751
Sale price1.379,93 €
|
Valrubicin Resolution Mixture (25 mg) (valrubicin spiked with seven related substances) |
F0I131 | N/A | 1.379,93 € | |
|
USP-1708773
Sale price1.258,41 €
|
Valsartan Related Compound A (10 mg) (N-Valeryl-N-{[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}D-valine) |
R142P0 | 137862-87-4 | 1.258,41 € | |
|
USP-1708784
Sale price1.312,16 €
|
Valsartan Related Compound B (10 mg) (N-butyryl-N-{[2'-(1H-tetrazole-5-yl)-biphenyl-4-yl]methyl}-L-valine) |
R099B0 | 952652-79-8 | 1.312,16 € | |
|
USP-1708795
Sale price1.353,06 €
|
Valsartan Related Compound C (10 mg) (N-Valeryl-N-{[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}-L-valine benzyl ester) |
R153S0 | 137863-20-8 | 1.353,06 € | |
|
USP-1708810
Sale price1.055,10 €
|
Valsartan Related Compound E (15 mg) (N-valeryl-N-{[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}-L-valine methyl ester) |
F008N0 | 137863-17-3 | 1.055,10 € | |
|
USP-1709018
Sale price1.113,53 €
|
Vancomycin B with Monodechlorovancomycin (300 mg) |
R23760 | N/A | 1.113,53 € | |
|
USP-1711064
Sale price1.181,30 €
|
Vardenafil Related Compound D (25 mg) (2-{2-Ethoxy-5-[(4-ethyl-4-oxidopiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propyl-imidazo[5,1-f][1,2,4]triazin-4(3H)-one) |
F137U0 | 448184-48-3 | 1.181,30 € |
